Reproductive Health Hotline Receives Our 100th Call! Topic: MGen

Updates from ReproHH

The latest updates, announcements, and clinical information from the Reproductive Health Hotline

Reproductive Health Hotline Receives Our 100th Call! Topic: MGen

A green information graphic that states "The Reproductive Health Hotline has received its 100th Call!"

 

Last week, we crossed an exciting milestone here at the Reproductive Health Hotline: Answering our 100th call! Since our launch this summer, call volume has been growing steadily, and we are pleased to have surpassed the triple-digit mark. 

The topic of our 100th call was on Mycoplasma genitalium, sometimes known as “Mgen."

What is Mgen?

Mgen is a lesser-known sexually transmitted infection (STI) that is often asymptomatic, but can also be a potential source for cervicitis, urethritis, or potentially pelvic inflammatory disease (PID).

How Should I Manage Mgen?

Mgen should always be tested for when a patient is experiencing recurrent or refractory symptoms, either through urine or a vaginal swab. 

Because Mgen often demonstrates macrolide resistance, treatment is a two-step process: The sequential use of doxycycline first to decrease bacterial load, followed by moxifloxacin for a >90% success rate. 

Resources

A few good resources to learn more about Mgen include the CDC Treatment Guidelines or the National STD Curriculum.

Still have questions? Have you seen a patient with complaints of discharge that persists despite treatment? We look forward to answering your calls, whether about Mgen, STIs more broadly, or any other aspect of sexual and reproductive health. Call us at 1-844-ReproHH (1-844-737-7644).